With the increased scrutiny surrounding the 340B drug discount program, many healthcare providers are taking a closer look at their programs. PwC is helping providers build a holistic view of their 340B program by bringing together disparate data sources, to evaluate risks, costs, and benefits.
The pharmaceutical industry is turning to value-based contracts to reduce pressure on drug pricing.
Higher ed faces key planning considerations in light of potential changes brought by the Trump administration, along with ongoing demands.
Supply Chain departments in healthcare organizations can add significant value to their procure-to-pay process with an eMarketplace solution.